Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06244771
Title A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors (PROSPER)
Acronym PROSPER
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Frontier Medicines Corporation
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.